Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02131064 |
|---|---|
| Brief Title: | A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer |
| First Submitted : | May 2, 2014 |
| First Submitted that Met QC Criteria : | May 2, 2014 |
| First Posted : | May 6, 2014 (Estimate) |
| Results First Submitted : | December 3, 2016 |
| Results First Submitted that Met QC Criteria : | May 9, 2017 |
| Results First Posted : | June 8, 2017 |
| Last Update Submitted that Met QC Criteria : | June 25, 2019 |
| Last Update Posted : | July 2, 2019 |